AU2002224838B9 - Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases - Google Patents

Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases Download PDF

Info

Publication number
AU2002224838B9
AU2002224838B9 AU2002224838A AU2002224838A AU2002224838B9 AU 2002224838 B9 AU2002224838 B9 AU 2002224838B9 AU 2002224838 A AU2002224838 A AU 2002224838A AU 2002224838 A AU2002224838 A AU 2002224838A AU 2002224838 B9 AU2002224838 B9 AU 2002224838B9
Authority
AU
Australia
Prior art keywords
seq
acid sequences
nucleic acid
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002224838A
Other languages
English (en)
Other versions
AU2002224838B2 (en
AU2002224838A1 (en
Inventor
Christophe Echeverri
Pierre Goenczy
Anthony Hyman
Steven Jones
Matthew Kirkham
Karen Oegema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cenix BioScience GmbH
Original Assignee
Cenix BioScience GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenix BioScience GmbH filed Critical Cenix BioScience GmbH
Publication of AU2002224838A1 publication Critical patent/AU2002224838A1/en
Application granted granted Critical
Publication of AU2002224838B2 publication Critical patent/AU2002224838B2/en
Publication of AU2002224838B9 publication Critical patent/AU2002224838B9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002224838A 2000-11-09 2001-11-09 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases Ceased AU2002224838B9 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24675000P 2000-11-09 2000-11-09
US60/246,750 2000-11-09
PCT/EP2001/013034 WO2002038805A2 (en) 2000-11-09 2001-11-09 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases

Publications (3)

Publication Number Publication Date
AU2002224838A1 AU2002224838A1 (en) 2002-07-25
AU2002224838B2 AU2002224838B2 (en) 2006-07-27
AU2002224838B9 true AU2002224838B9 (en) 2007-02-08

Family

ID=22932039

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002224838A Ceased AU2002224838B9 (en) 2000-11-09 2001-11-09 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
AU2483802A Pending AU2483802A (en) 2000-11-09 2001-11-09 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2483802A Pending AU2483802A (en) 2000-11-09 2001-11-09 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases

Country Status (9)

Country Link
US (1) US7368248B2 (enExample)
EP (1) EP1334123B1 (enExample)
JP (1) JP2004526421A (enExample)
AT (1) ATE405585T1 (enExample)
AU (2) AU2002224838B9 (enExample)
CA (1) CA2428438C (enExample)
DE (1) DE60135482D1 (enExample)
DK (1) DK1334123T3 (enExample)
WO (1) WO2002038805A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8202979B2 (en) 2002-02-20 2012-06-19 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
WO2003070918A2 (en) 2002-02-20 2003-08-28 Ribozyme Pharmaceuticals, Incorporated Rna interference by modified short interfering nucleic acid
US7517864B2 (en) 2001-05-18 2009-04-14 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20050148530A1 (en) 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US9994853B2 (en) 2001-05-18 2018-06-12 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
AU2003207708A1 (en) 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
JP2007511216A (ja) * 2003-11-17 2007-05-10 クルセイド ラボラトリーズ リミテッド 変異ウイルス
JP2007523649A (ja) 2004-02-10 2007-08-23 サーナ・セラピューティクス・インコーポレイテッド 多機能短鎖干渉核酸（多機能ｓｉＮＡ）を用い、ＲＮＡ干渉を介した遺伝子発現の阻害
WO2005105157A2 (en) 2004-04-23 2005-11-10 The Trustees Of Columbia University In The City Ofnew York INHIBITION OF HAIRLESS PROTEIN mRNA
US10508277B2 (en) 2004-05-24 2019-12-17 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
US9708619B2 (en) 2005-09-20 2017-07-18 Basf Plant Science Gmbh Methods for controlling gene expression using ta-siRNA
DK2129680T3 (en) 2007-03-21 2015-08-10 Brookhaven Science Ass Llc COMBINED hairpin ANTISENSE COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF
KR101605932B1 (ko) 2009-12-18 2016-03-24 노파르티스 아게 Ｈｓｆ1-관련 질환을 치료하기 위한 유기 조성물
AU2011214465A1 (en) 2010-02-10 2012-08-30 Novartis Ag Methods and compounds for muscle growth
EP3766975A1 (en) 2010-10-29 2021-01-20 Sirna Therapeutics, Inc. Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910962D0 (en) 1989-05-12 1989-06-28 Natural Environment Res Novel baculovirus expression vectors and use thereof in the expression of foreign proteins in insects or insect cells
US5162222A (en) * 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
US5155037A (en) * 1989-08-04 1992-10-13 The Texas A&M University System Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
D1, EMBL Accession no AL024499 *
D2, EMBL Accession no L14745 *
D3, EMBL Accession no L10986 *
D4, EMBL Accession no C64048 *
D5 EMBL Accession no M79698 *
D6, EMBL Accession no AF292100 *

Also Published As

Publication number Publication date
DE60135482D1 (de) 2008-10-02
WO2002038805A8 (en) 2007-07-05
EP1334123A2 (en) 2003-08-13
AU2483802A (en) 2002-05-21
CA2428438A1 (en) 2002-05-16
US7368248B2 (en) 2008-05-06
WO2002038805A2 (en) 2002-05-16
AU2002224838B2 (en) 2006-07-27
ATE405585T1 (de) 2008-09-15
WO2002038805A3 (en) 2003-02-13
DK1334123T3 (da) 2009-01-12
US20040048277A1 (en) 2004-03-11
JP2004526421A (ja) 2004-09-02
EP1334123B1 (en) 2008-08-20
CA2428438C (en) 2012-09-25

Similar Documents

Publication Publication Date Title
AU2002224838B2 (en) Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
AU2002224838A1 (en) Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
Lui et al. Binding partners for the COOH-terminal appendage domains of the GGAs and γ-adaptin
Fowler et al. Characterization of hydra type IV collagen: type IV collagen is essential for head regeneration and its expression is up-regulated upon exposure to glucose
JP2003516124A (ja) 標的とした遺伝的干渉の手段としてのｒｎａ干渉経路遺伝子
Ochi et al. CCDC61/VFL3 is a paralog of SAS6 and promotes ciliary functions
EP1682573B1 (en) The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases
AU2002227917B2 (en) Genes required for viability and/or reproduction in C. elegans and their use in the development of anti-nematode agents
US7479369B2 (en) Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases
AU2002227917A1 (en) Genes required for viability and/or reproduction in C. elegans and their use in the development of anti-nematode agents
US20050003363A1 (en) Method of screening for agents inhibiting chloride intracellular channels
US20070042981A1 (en) Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
Petzold et al. Cells determine cell density using a small protein bound to a unique tissue-specific phospholipid
WO2000049048A1 (en) Ndae1 - a new bicarbonate transporter
Huang Mutagenesis and functional analysis of dveli, the Drosophila ortholog of C. elegans lin-7
WO2001038531A1 (fr) Nucleoproteine humaine possedant un domaine www et polynucleotide codant cette nucleoproteine

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired